MedTrace Logo

A Preference Study Comparing Kristalose® and Liquid Lactulose

NCT00712543 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-09-27

Study results available
· View outcomes & findings →

Summary

This study will evaluate whether patients have an overall preference for Kristalose® or liquid lactulose based on taste, consistency, and portability.

Conditions

Interventions

DRUG

lactulose (Kristalose®)

Crystals to be dissolved in water and taken as prescribed.

DRUG

liquid lactulose

Liquid to be taken as prescribed.

Sponsors & Collaborators

  • Cumberland Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00712543 on ClinicalTrials.gov